Loading people...
Gladys Nunez is the Managing Director at Amgen Ventures, based in the Greater Los Angeles Area. In this capacity, she leads corporate venture investments in early-stage biotechnology and healthcare startups, specifically managing the firm's R&D Seed Fund. She brings over two decades of biopharmaceutical experience to her investment strategy, having previously served in multiple leadership positions at Amgen, including Executive Director of Business Development and Director of Licensing. Nunez holds a Master of Business Administration from Pepperdine University and a bachelor's degree from the University of Puerto Rico. She frequently serves as a board member or observer for portfolio companies advancing therapeutics and drug discovery platforms from the seed stage through Series B funding rounds. Her current focus centers on funding and partnering with early-stage life sciences companies to advance novel therapeutics and healthcare technologies.
Gladys Nunez is a distinguished Managing Director at Amgen Ventures, the corporate venture capital arm of Amgen, one of the world's leading biotechnology companies. In her crucial role, Gladys is instrumental in shaping Amgen's future by investing in innovative startups and emerging companies that are at the forefront of scientific discovery and therapeutic development. Her work directly supports Amgen's strategic objectives, seeking out opportunities that can complement and expand Amgen's pipeline and technological capabilities.
Amgen Ventures, under the guidance of leaders like Gladys Nunez, focuses on a broad spectrum of investment areas within the life sciences. These typically include novel therapeutics across various modalities, platform technologies, and digital health solutions that have the potential to significantly impact patient care. Specific areas of interest often align with Amgen's core therapeutic areas, such as oncology, immunology, inflammation, neuroscience, cardiovascular and metabolic diseases, and rare diseases. Gladys evaluates companies based on their scientific rigor, clinical potential, management team, and market opportunity, ensuring that investments are not only financially sound but also strategically valuable.
While specific details of Gladys Nunez's career background prior to Amgen Ventures are not publicly detailed in this profile, her position as Managing Director strongly suggests a robust history in venture capital, corporate development, or a scientific leadership role within the biotechnology or pharmaceutical industry. Such a role demands a deep understanding of drug discovery and development processes, regulatory pathways, and the commercial landscape of healthcare. Her expertise likely encompasses deal sourcing, due diligence, portfolio management, and providing strategic guidance to early-stage companies as they navigate the complex journey from concept to commercialization.
Gladys Nunez's contributions at Amgen Ventures are vital for fostering innovation within the biotech ecosystem. By identifying and nurturing promising ventures, she helps accelerate the development of new medicines and technologies that can address unmet medical needs globally. Her work exemplifies Amgen Ventures' commitment to supporting the next generation of life science breakthroughs, ultimately benefiting patients worldwide.
Gladys Nunez is a Managing Director at Amgen Ventures, the corporate venture capital arm of Amgen. She focuses on strategic investments in innovative biotechnology and life science companies.
Gladys Nunez invests in groundbreaking companies within the biotechnology and life sciences sectors. Her investment focus includes novel therapeutics, platform technologies, and digital health solutions, often aligning with Amgen's core therapeutic areas like oncology, immunology, and neuroscience.
Gladys Nunez works at Amgen Ventures, serving as a Managing Director. Amgen Ventures is the corporate venture capital fund of Amgen, a leading global biotechnology company.
